Status:
COMPLETED
Aflibercept With and Without Micropulse Laser in Diabetic Macular Edema
Lead Sponsor:
Al Hadi Hospital
Conditions:
Diabetic Macular Edema
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
prospective study evaluating the impact of subthreshold micropulsed laser on the number of Aflibercept injections when used as an adjuvant therapy in eyes with diabetic macular edema.
Eligibility Criteria
Inclusion
- older than 18 years old
- diagnosed with DME with central macular thickness (CMT) more than 250 µm measured by OCT
- best corrected visual acuity (BCVA) between 20/400 and 20/40.
Exclusion
- patients with intra-ocular surgery as cataract surgery within 6 months
- prior intravitreal injection of any drug within the preceding 6 months
- panretinal photocoagulation (PRP) within the former 4 months.
- Patients with previous macular laser
- patients with vitreo-macular traction (VMT) syndrome
- severe glaucoma
- other retinal vascular diseases
- conditions that impede the OCT interpretation
Key Trial Info
Start Date :
May 8 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 28 2018
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT03866746
Start Date
May 8 2017
End Date
December 28 2018
Last Update
July 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AlHadi hospital
Hawalli, AlJabryia, Kuwait, 123